Goutelle, S.; Guidi, M.; Gotta, V.; Csajka, C.; Buclin, T.; Widmer, N.
From Personalized to Precision Medicine in Oncology: A Model-Based Dosing Approach to Optimize Achievement of Imatinib Target Exposure. Pharmaceutics 2023, 15, 1081.
https://doi.org/10.3390/pharmaceutics15041081
AMA Style
Goutelle S, Guidi M, Gotta V, Csajka C, Buclin T, Widmer N.
From Personalized to Precision Medicine in Oncology: A Model-Based Dosing Approach to Optimize Achievement of Imatinib Target Exposure. Pharmaceutics. 2023; 15(4):1081.
https://doi.org/10.3390/pharmaceutics15041081
Chicago/Turabian Style
Goutelle, Sylvain, Monia Guidi, Verena Gotta, Chantal Csajka, Thierry Buclin, and Nicolas Widmer.
2023. "From Personalized to Precision Medicine in Oncology: A Model-Based Dosing Approach to Optimize Achievement of Imatinib Target Exposure" Pharmaceutics 15, no. 4: 1081.
https://doi.org/10.3390/pharmaceutics15041081
APA Style
Goutelle, S., Guidi, M., Gotta, V., Csajka, C., Buclin, T., & Widmer, N.
(2023). From Personalized to Precision Medicine in Oncology: A Model-Based Dosing Approach to Optimize Achievement of Imatinib Target Exposure. Pharmaceutics, 15(4), 1081.
https://doi.org/10.3390/pharmaceutics15041081
